Compare EUDA & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EUDA | IRIX |
|---|---|---|
| Founded | 2021 | 1989 |
| Country | Singapore | United States |
| Employees | 117 | N/A |
| Industry | Blank Checks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 23.2M |
| IPO Year | N/A | 1996 |
| Metric | EUDA | IRIX |
|---|---|---|
| Price | $6.67 | $1.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $55.00 | N/A |
| AVG Volume (30 Days) | 8.4K | ★ 161.5K |
| Earning Date | 12-19-2023 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,593,000.00 |
| Revenue This Year | $134.73 | $3.07 |
| Revenue Next Year | $195.03 | $6.66 |
| P/E Ratio | $123.62 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.33 | $0.87 |
| 52 Week High | $15.36 | $1.65 |
| Indicator | EUDA | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 50.14 | 40.84 |
| Support Level | $2.09 | $0.99 |
| Resistance Level | $15.36 | $1.20 |
| Average True Range (ATR) | 0.74 | 0.05 |
| MACD | -0.51 | 0.01 |
| Stochastic Oscillator | 14.74 | 50.10 |
EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.